By Professor Nada Hamad

Journal articles

Wilson MR; Eyre TA; Kirkwood AA; Doo NW; Soussain C; Choquet S; Martinex-Calle N; Preston G; Ahearne MJ; Schorb E; Moles-Moreau M-P; Ku M; Rusconi C; Khwaja J; Narkhede M; Lewis KL; Calimeri T; Durot E; Renaud L; Ovlisen AK; McIlroy G; Ebsworth T; Elliot J; Santarsiere A; Ricard L; Shah N; Liu Q; Zayac A; Vassallo F; Lebras L; Roulin L; Lombion N; Manos K; Fernandez R; Hamad N; Lopez-Garcia A; O'Mahony D; Gounder P; Forgeard N; Lees C; Agbetiafa K; Struesmann T; Htut TW; Clavert A; Scott HW; Guidetti A; Barlow BR; Smith J; El-Galaly TC; Cheah CY; Ferreri AJM; Miall F; Fox CP; Cwynarski K; McKay P, 2021, 'Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treat ent Delivery: A Multicentre International Analysis of 1384 Patients', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-144820

Di Ciaccio PR; Campbell B; Mason KD; Shanavas M; Greenwood M; Gregory GP; Eslick R; Kidson-Gerber G; Tang C; Morris KL; Smallbone P; Badoux X; Shipton MJ; McKeague SJ; Langfield J; Goss K; Hamad N, 2021, 'Lymphoma during Pregnancy: A Multicentre Study By the Australasian Lymphoma Alliance', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-150538

Perram J; Mayson E; Tang C; Tran S; Aarons D; Dodds AJ; Fay K; Hamad N; Ma D; Milliken S; Withers B; Greenwood M; Stevenson WS; Arthur CK; Kerridge IH; Moore J, 2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106

Lee S; Locatelli F; Ayuk FA; Zuckerman T; Fukushima K; Llamas JCV; Pidala J; Hamad N; Moiseev IS; Bonifazi F; Apte S; Zeiser R; Bhatt V; Gowda M; Han J; Stefanelli T; Zuurman MW; Teshima T, 2021, 'Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT)', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-144576

Tatarczuch M; Lewis KL; Gunjur A; Shaw B; Poon M; Paul E; Ku M; Wong M; Beekman A; Krigstein M; Di Ciaccio PR; Wight J; Coombes C; Gilbertson M; Tey A; Shortt J; Nagarajan C; Latimer M; Talaulikar D; Hamad N; Ratnasingam S; Cochrane T; Hawkes E; Cheah CY; Opat S; Gregory GP, 2021, 'Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-145959

Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149354

White J; Elemary M; Linn SM; Novitzky-Basso I; Xenocostas A; Hamad N; Culos S; Tan S; Law A; Kumar R; Mattsson J; Dennis D; Kim H, 2021, 'Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-148859

Boyle S; Tobin JWD; Perram J; Hamad N; Gullapalli V; Barraclough A; Singaraveloo L; Han MH; Blennerhassett R; Nelson N; Johnston AM; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Jabbour A; Strasser SI; Chadban SJ; Brown C; Mollee P; Hapgood G, 2021, 'Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study from the Australasian Lymphoma Alliance', HemaSphere, 5, pp. E648, http://dx.doi.org/10.1097/HS9.0000000000000648

Farooq F; Cardonick E; Polushkina E; Ahmed S; Ramakrishnan P; Olszewski AJ; Yasin H; Hamad N; Lin Y; Edmonds J; Ciavolino L; Maggen C; Fruscio R; Gziri MM; Steffensen KD; Farooq U; Amant F; Sharon E; Yin T; Figg WD; Brandt J; Peer C; Vose JM; Evens AM, 2021, 'A Multi-Institution Analysis of Relapsed Lymphoma Occurring during Pregnancy Including Pharmacokinetics with Antenatal Checkpoint Inhibitor Therapy', Blood, 138, pp. 2457 - 2457, http://dx.doi.org/10.1182/blood-2021-149220

Dickinson M; Hamad N; Bryant CE; Borthakur G; Hosing C; Shook D; Tan J; Rajangam K; Liu H; Kennedy GA; McSweeney PA; Hill BT, 2021, 'A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies', Blood, 138, pp. 3868 - 3868, http://dx.doi.org/10.1182/blood-2021-146602

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson A-M; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2021, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry', Blood, 138, pp. 2929 - 2929, http://dx.doi.org/10.1182/blood-2021-149939

Mills G; Moore J; Cliff E; Fong CY; Mangalasseril S; Tiley C; Gilbertson M; Ku M; Bazargan A; Bryson M; Menzies Wojtowicz M; Sungala NP; Cunningham I; Tang C; Hamad N, 2021, 'Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study', Blood, 138, pp. 2570 - 2570, http://dx.doi.org/10.1182/blood-2021-152131

Novitzky-Basso I; Linn SM; White J; Elemary M; Xenocostas A; Hamad N; Tan S; Culos S; Law A; Kim DDH, 2021, 'Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure', Blood, 138, pp. 1805 - 1805, http://dx.doi.org/10.1182/blood-2021-151683

Walker SK; Harrop S; Di Ciaccio P; Lewis KL; Boles R; Tedjaseputra A; Hamad N; Hodges G; Yannakou CK; Tam CS; Opat S; Cheah CYY; Ku M, 2021, 'Real World Data on the Outcomes of Richter's Transformation of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in the Australian Population: An Australasian Lymphoma Alliance Study', Blood, 138, pp. 1455 - 1455, http://dx.doi.org/10.1182/blood-2021-147146

Lim KJC; Di Ciaccio P; Hamad N; Polizzotto MN; Milliken S; Cochrane T; Goh Z; Shaw B; Perry E; Gilbertson M; Kermode W; Cheah CY; Latimer M; Ku M, 2021, 'Real-World Outcomes of Aggressive B-Cell Non-Hodgkin Lymphoma in People Living with HIV (PLWH) Treated in Australia: An Australasian Lymphoma Alliance Study', Blood, 138, pp. 1456 - 1456, http://dx.doi.org/10.1182/blood-2021-144817

Minson A; Hamad N; Yannakou CK; Wong SM; Butler JP; Seymour JF; Dickinson M, 2021, 'Trial in Progress: A Multicentre, Parallel Arm, Open-Label Trial of Frontline R-CHOP/Polatuzumab Vedotin-RCHP and Glofitamab in Younger Patients with Higher Risk Diffuse Large B Cell Lymphoma (COALITION)', Blood, 138, pp. 3571 - 3571, http://dx.doi.org/10.1182/blood-2021-147636

Chai KL; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622

Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2021, 'Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, 51, pp. 1869 - 1875, http://dx.doi.org/10.1111/imj.14973

R Di Ciaccio P; Emmett L; Hamad N, 2021, 'Qualitative study of nuclear medicine physicians' perceptions of positron emission tomography/computed tomography in pregnant patients with cancer', Internal Medicine Journal, 51, pp. 1722 - 1726, http://dx.doi.org/10.1111/imj.15515

Di Ciaccio PR; Mills G; Tang C; Hamad N, 2021, 'Managing haematological malignancies in pregnant women', The Lancet Haematology, 8, pp. e623 - e624, http://dx.doi.org/10.1016/S2352-3026(21)00242-8

MacIntyre CR; Veness B; Berger D; Hamad N; Bari N, 2021, 'Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk–benefit analysis for people < 60 years in Australia', Vaccine, 39, pp. 4784 - 4787, http://dx.doi.org/10.1016/j.vaccine.2021.07.013

Hamad N; Ananda-Rajah M; Gilroy N; MacIntyre R; Gottlieb D; Ritchie D; Harrison S; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Milliken S; Bardy P; Larsen S; Ho PJ; Lai H; Bajel A; Butler J; Tiley C; D'Rozario J; Johnston A; Cochrane T; Mills T; Irving I; Pullon H; Purtill D, 2021, 'Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement', Internal Medicine Journal, 51, pp. 1321 - 1323, http://dx.doi.org/10.1111/imj.15263

Zeiser R; Polverelli N; Ram R; Hashmi SK; Chakraverty R; Middeke JM; Musso M; Giebel S; Uzay A; Langmuir P; Hollaender N; Gowda M; Stefanelli T; Lee SJ; Teshima T; Locatelli F, 2021, 'Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease', NEW ENGLAND JOURNAL OF MEDICINE, 385, pp. 228 - 238, http://dx.doi.org/10.1056/NEJMoa2033122

Scordo M; Wang TP; Ahn KW; Chen Y; Ahmed S; Awan FT; Beitinjaneh A; Chen A; Chow VA; Dholaria B; Epperla N; Farooq U; Ghosh N; Grover N; Hamad N; Hildebrandt GC; Holmberg L; Hong S; Inwards DJ; Jimenez-Jimenez A; Karmali R; Kenkre VP; Khimani F; Klyuchnikov E; Krem MM; Munshi PN; Nieto Y; Prestidge T; Ramakrishnan Geethakumari P; Rezvani AR; Riedell PA; Seo S; Shah NN; Solh M; Yared JA; Kharfan-Dabaja MA; Herrera A; Hamadani M; Sauter CS, 2021, 'Outcomes Associated with Thiotepa-Based Conditioning in Patients with Primary Central Nervous System Lymphoma after Autologous Hematopoietic Cell Transplant', JAMA Oncology, 7, pp. 993 - 1003, http://dx.doi.org/10.1001/jamaoncol.2021.1074

Tang C; Hamad N, 2021, 'Trials and tribulations: including women in cancer clinical research', The Lancet Haematology, 8, pp. e477 - e478, http://dx.doi.org/10.1016/S2352-3026(21)00165-4

McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247

Shah J; Shacham S; Kauffman M; Daniele P; Tomaras D; Tremblay G; Casasnovas RO; Maerevoet M; Zijlstra J; Follows G; P Vermaat JS; Kalakonda N; Goy AH; Choquet S; Den Neste EV; Hill BT; Thieblemont C; Cavallo F; La Cruz FD; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos TP; Samal P; Nagy A; Ku M; Canales Albendea MÁ, 2021, 'Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma', Future Oncology, 17, pp. 1295 - 1310, http://dx.doi.org/10.2217/fon-2020-0946

Ross DM; Thomson C; Hamad N; Lane SW; Manos K; Grigg AP; Guo B; Erber WN; Scott A; Viiala N; Chee L; Latimer M; Tate C; Grove C; Perkins AC; Blombery P, 2021, 'Myeloid somatic mutation panel testing in myeloproliferative neoplasms', Pathology, 53, pp. 339 - 348, http://dx.doi.org/10.1016/j.pathol.2021.01.003

Lewis KL; Chin CK; Manos K; Casey J; Hamad N; Crawford J; Ho SJ; Issa S; Grigg A; Wood P; Gandhi MK; Do B; Nastoupil L; Hawkes EA; Cheah CY, 2021, 'Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience', British Journal of Haematology, 192, pp. 1049 - 1053, http://dx.doi.org/10.1111/bjh.16946

Connolly EA; Weickhardt AJ; Grimison PS; Heller G; Lewin JH; Liow ECH; Tung I; Tran B; Hill S; Walpole ET; McKenzie J; Kuchel A; Forgeson G; Tan ABT; Joshi A; Wickham A; Tan TH; Wang Y; Hamad N; Wong V, 2021, 'Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR.', JOURNAL OF CLINICAL ONCOLOGY, 39, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.382

Blennerhassett R; Purtill D; Hamad N, 2021, 'Letter to the Editor Regarding “Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia”', Transplantation and Cellular Therapy, 27, pp. 190 - 191, http://dx.doi.org/10.1016/j.jtct.2020.11.011

Wight J; Hamad N; Campbell BA; Ku M; Lee K; Rose H; Armytage T; Latimer M; Lee HP; Lee ST; Dickinson M; Khor R; Verner E, 2021, 'Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.15533

Di Ciaccio PR; Ritchie DS; Kennedy G; Milliken S; Purtill D; Gottlieb D; Perera T; Yeung DT; Larsen SR; Doocey RT; Greenwood M; Durrant S; Watson A-M; Butler A; Khot A; Curley C; Hamad N, 2021, 'Allogeneic Haematopoietic Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S394 - S395, http://dx.doi.org/10.1016/s2666-6367(21)00509-1

Di Ciaccio PR; Greenwood M; Kennedy G; Milliken S; Gottlieb D; Ritchie DS; Purtill D; Larsen SR; Spencer A; Perera T; Yeung DT; Durrant S; Butler A; Watson A-M; Lai HC; Doocey RT; Goodman HJ; Kerridge IH; Arthur C; Curley C; Stewart C; Micklethwaite K; Collins J; Cooney JP; Hamad N, 2021, 'Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S394 - S394, http://dx.doi.org/10.1016/s2666-6367(21)00508-x

Barge L; Tran S; Kennedy G; Ritchie DS; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey RT; Larsen S; Butler A; Bardy P; Greenwood M; Durrant S; Curley C; Stewart C; Tam CS; Collins J; Balendran S; Di Ciaccio PR; Patil S; Han M-H; Hamad N, 2021, 'Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S133 - S135, http://dx.doi.org/10.1016/s2666-6367(21)00168-8

Lwin Y; Kennedy G; Gottlieb D; Kwan J; Ritchie D; Szer J; Milliken S; Browett P; Spencer A; Butler A; Bardy P; Greenwood M; Perera T; He S; McEwan A; Larsen S; Lai H; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry', Biology of Blood and Marrow Transplantation, 26, pp. 2252 - 2261, http://dx.doi.org/10.1016/j.bbmt.2020.08.024

Wang J; Asch AS; Hamad N; Weickhardt A; Tomaszewska-Kiecana M; Dlugosz-Danecka M; Pylypenko H; Bahadur S; Ulahannan S; Koucheki J; Sun J; Li H; Chen F; Zhang X; Muth J; Kaminker P; Moore P; Sumrow BJ, 2020, 'A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma', Blood, 136, pp. 21 - 22, http://dx.doi.org/10.1182/blood-2020-139868

Minson A; Hamad N; Butler JP; Westerman DA; Ritchie D; Blombery P; Seymour JF; Tam CS; Dickinson M, 2020, 'A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)', Blood, 136, pp. 34 - 35, http://dx.doi.org/10.1182/blood-2020-138946

Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131

Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209

Boyle S; Tobin JWD; Perram J; Hamad N; Barraclough A; Singaraveloo L; Han M-H; Blennerhassett R; Nelson NE; Johnston A; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Gullapalli V; Jabbour A; Strasser S; Chadban S; Brown C; Mollee P; Hapgood G, 2020, 'Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance', Blood, 136, pp. 36 - 38, http://dx.doi.org/10.1182/blood-2020-140665

White J; Hamad N; Linn SM; Novitzky-Basso IN; Abduljalil O; Law A; Kim DDH, 2020, 'Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment', Blood, 136, pp. 45 - 47, http://dx.doi.org/10.1182/blood-2020-136164

Benajiba L; Carraway HE; Hamad N; Stein EM; Yannakou CK; Burroughs A; Harris S; Lane H; Nguyen DD; Stuart M; Vargas J; Puissant A; Stegmaier K; DiNardo CD, 2020, 'Trials in Progress: A Phase I Study to Evaluate the Safety and Pharmacokinetic Profiles of CB-5339 in Participants with Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Intermediate or High-Risk Myelodysplastic Syndrome', Blood, 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-140636

Paterson JA; Hwang A; Wong S; Sewell W; Joseph JE; Hamad N, 2020, 'Two Rare Cases of Severe Autoimmune Dyserythropoiesis without Any Underlying Haematological Malignancy or Autoimmune Disease', Blood, 136, pp. 2 - 3, http://dx.doi.org/10.1182/blood-2020-142281

Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030

Purtill D; Antonenas V; Chiappini P; Tong D; O’Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai LJ; Greenwood M; Gottlieb DJ; Hamad N, 2020, 'Variable CD34¹ recovery of cryopreserved allogeneic HPC products: Transplant implications during the COVID-19 pandemic', Blood Advances, 4, pp. 4147 - 4150, http://dx.doi.org/10.1182/bloodadvances.2020002431

Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D, 2020, 'Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation', Biology of Blood and Marrow Transplantation, 26, pp. 1711 - 1718, http://dx.doi.org/10.1016/j.bbmt.2020.03.005

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Manuel Sancho J; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin J-R; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B -cell lymphoma (SADAL): a single -arm, multinational, multicentre, open -label, phase 2 trial', LANCET HAEMATOLOGY, 7, pp. E509 - E522, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000544758900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Sancho JM; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin JR; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van Den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial', The Lancet Haematology, 7, pp. e511 - e522, http://dx.doi.org/10.1016/S2352-3026(20)30120-4

Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859

Back to profile page